Jensen, C.; Sinkeviciute, D.; Madsen, D.H.; Önnerfjord, P.; Hansen, M.; Schmidt, H.; Karsdal, M.A.; Svane, I.M.; Willumsen, N.
Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade. Cancers 2020, 12, 2786.
https://doi.org/10.3390/cancers12102786
AMA Style
Jensen C, Sinkeviciute D, Madsen DH, Önnerfjord P, Hansen M, Schmidt H, Karsdal MA, Svane IM, Willumsen N.
Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade. Cancers. 2020; 12(10):2786.
https://doi.org/10.3390/cancers12102786
Chicago/Turabian Style
Jensen, Christina, Dovile Sinkeviciute, Daniel Hargbøl Madsen, Patrik Önnerfjord, Morten Hansen, Henrik Schmidt, Morten Asser Karsdal, Inge Marie Svane, and Nicholas Willumsen.
2020. "Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade" Cancers 12, no. 10: 2786.
https://doi.org/10.3390/cancers12102786
APA Style
Jensen, C., Sinkeviciute, D., Madsen, D. H., Önnerfjord, P., Hansen, M., Schmidt, H., Karsdal, M. A., Svane, I. M., & Willumsen, N.
(2020). Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade. Cancers, 12(10), 2786.
https://doi.org/10.3390/cancers12102786